Hypocretin/orexin modulation of cognitive correlates of brain aging
下丘脑分泌素/食欲素对大脑衰老认知相关性的调节
基本信息
- 批准号:8937397
- 负责人:
- 金额:$ 28.65万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-08-15 至 2020-05-31
- 项目状态:已结题
- 来源:
- 关键词:AcetylcholineAcuteAge-MonthsAge-associated memory impairmentAgingAlzheimer&aposs DiseaseAnimal ModelAnimalsArousalAttentionBehaviorBehavioralBiological PreservationBody CompositionBrain regionCellsChronicClinicalClinical ResearchCognitionCognitiveCognitive agingCognitive deficitsDesigner DrugsDiseaseEatingElderlyFunctional disorderGene TransferGlutamatesHippocampus (Brain)HomeostasisHypothalamic structureImpaired cognitionInsula of ReilLeadLearningLesionLinkLiteratureLongevityMaintenanceMediatingMediator of activation proteinMemoryMetabolicNerve DegenerationNeurobehavioral ManifestationsNeurobiologyNeuronsNeuropeptidesNeurotransmittersParkinson DiseasePatternPerformancePhysiologicalPlayPopulationPreventionProcessRegulationResourcesRoleSleepSleep Wake CycleStimulusSupport SystemSyndromeSystemTestingUp-RegulationVirusWater consumptionWorkage effectage relatedaging brainbasal forebraincholinergicclinically significantcognitive changecognitive functioncognitive performanceenergy balanceexecutive functionfeedingfrailtyhypocretinin vivojuvenile animalmiddle agenervous system disorderneurobiological mechanismneurochemistryneurocognitive disorderneuron lossneurotransmissionnew therapeutic targetnovelpreventpublic health relevancereceptorrelating to nervous systemresearch studyresponserestorationsustained attentiontheoriestherapeutic targettherapy developmenttransmission process
项目摘要
DESCRIPTION (provided by applicant): The aging U.S. population has led to substantial increases in resources allocated to the prevention and treatment of age-related neurodegenerative conditions, including disorders of cognitive decline. Alterations in homeostatic functions such as energy balance and sleep patterns are also frequently seen in the elderly and these changes often precede and predict subsequent cognitive decline. A novel hypothesis is that some of these seemingly disparate manifestations of age-related deficits may share underlying neurobiological mechanisms; that is, brain regions that are involved in homeostasis regulate the activity of neurotransmitter systems and brain regions that mediate the appropriate behavioral and cognitive responses to physiological challenges, and these interactions may be impacted in aging. We have shown that aging is associated with loss of hypothalamic hypocretin/orexin neurons-a cell population that regulates energy balance and sleep/wake stability. Because hypocretin/orexin neurons also regulate neurotransmission in brain regions that underlie several aspects of attention, learning and memory we hypothesize that these neuropeptides link physiological function with age-related cognitive decline. The testable corollary to this hypothesis is that upregulation of the orexin/hypocretin system in aging
will allow for preservation or restoration of these functions. In Aim 1 we will combine DREADD (designer receptors exclusively activated by designer drugs) and in vivo neurochemical approaches to determine the effect of acute orexin/hypocretin activation or inhibition on behavior and neurotransmission in several relevant brain regions. In Aim 2 we will use virus-mediated gene transfer and to perform chronic manipulations of the orexin/hypocretin system in a longitudinal animal model of aging. We will examine how these manipulations alter food and water intake, body composition and markers of neurotransmitter systems and neuronal activation. In Aim 3 we will test the hypothesis that the hypocretin/orexin system supports attentional performance across the life span using both acute and chronic manipulations of hypocretin/orexin transmission. Collectively, these studies will implicate the orexin/hypocretin system as a major contributing factor in cognitive and homeostatic manifestations of age-related neural dysfunction, and suggest a potential new target for development of therapies that prevent, delay or ameliorate age-related cognitive decline.
描述(由申请人提供):美国人口老龄化导致用于预防和治疗与年龄相关的神经退行性疾病(包括认知能力下降疾病)的资源大幅增加。能量平衡和睡眠模式等稳态功能的改变也常见于老年人,这些变化通常先于并预测随后的认知能力下降。一个新的假设是,这些看似不同的年龄相关缺陷表现可能具有共同的神经生物学机制。也就是说,参与体内平衡的大脑区域调节神经递质系统的活动,以及调节对生理挑战的适当行为和认知反应的大脑区域,并且这些相互作用可能会在衰老过程中受到影响。我们已经证明,衰老与下丘脑下丘脑分泌素/食欲素神经元的丧失有关,下丘脑下丘脑分泌素/食欲素神经元是调节能量平衡和睡眠/觉醒稳定性的细胞群。由于下丘脑分泌素/食欲素神经元还调节大脑区域的神经传递,这些神经传递是注意力、学习和记忆多个方面的基础,因此我们假设这些神经肽将生理功能与年龄相关的认知衰退联系起来。该假设的可检验推论是,衰老过程中食欲素/下丘脑分泌素系统的上调
将允许保留或恢复这些功能。在目标 1 中,我们将结合 DREADD(仅由设计药物激活的设计受体)和体内神经化学方法来确定急性食欲素/下丘脑分泌素激活或抑制对几个相关大脑区域的行为和神经传递的影响。在目标 2 中,我们将使用病毒介导的基因转移,并在纵向衰老动物模型中对食欲素/下丘脑分泌素系统进行长期操作。我们将研究这些操作如何改变食物和水的摄入量、身体成分以及神经递质系统和神经元激活的标记。在目标 3 中,我们将测试以下假设:下丘脑分泌素/食欲素系统通过对下丘脑分泌素/食欲素传输的急性和慢性操作来支持整个生命周期的注意力表现。总的来说,这些研究将表明食欲素/下丘脑分泌素系统是与年龄相关的神经功能障碍的认知和稳态表现的主要影响因素,并为开发预防、延迟或改善与年龄相关的认知衰退的疗法提供了潜在的新目标。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JIM R FADEL其他文献
JIM R FADEL的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JIM R FADEL', 18)}}的其他基金
Hypocretin/orexin modulation of cognitive correlates of brain aging
下丘脑分泌素/食欲素对大脑衰老认知相关性的调节
- 批准号:
10445459 - 财政年份:2015
- 资助金额:
$ 28.65万 - 项目类别:
Hypocretin/orexin modulation of cognitive correlates of brain aging
下丘脑分泌素/食欲素对大脑衰老认知相关性的调节
- 批准号:
9120726 - 财政年份:2015
- 资助金额:
$ 28.65万 - 项目类别:
Amygdala NPY, anxiety phenotypes and alcohol consumption
杏仁核 NPY、焦虑表型和饮酒
- 批准号:
7414346 - 财政年份:2007
- 资助金额:
$ 28.65万 - 项目类别:
Amygdala NPY, anxiety phenotypes and alcohol consumption
杏仁核 NPY、焦虑表型和饮酒
- 批准号:
7504054 - 财政年份:2007
- 资助金额:
$ 28.65万 - 项目类别:
相似海外基金
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 28.65万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 28.65万 - 项目类别:
Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 28.65万 - 项目类别:
Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 28.65万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 28.65万 - 项目类别:
Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 28.65万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 28.65万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 28.65万 - 项目类别:
Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 28.65万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
- 批准号:
484000 - 财政年份:2023
- 资助金额:
$ 28.65万 - 项目类别:
Operating Grants














{{item.name}}会员




